News on immunohistochemistry and other tissue-based testing methods.
The La Jolla, California-based developer of genomic melanoma tests posted nearly $1.6 million in revenues in Q4, up from $600,000 in Q4 2018.
Both deals involve the Inspirata's steps to expand partnerships for its digital pathology solution, the Dynamyx case management platform.
The deal is aimed at providing technologies, products, and services that will improve the standardization of pathology labs and accelerate accurate diagnoses.
The company's approach involves using both fluorescence in situ hybridization and next-generation sequencing to provide clinicians with information.
